Copd Newswire

Comprehensive Real-Time News Feed for Copd.

Results 1 - 20 of 303 in Copd

  1. Theravance Biopharma: Neglected Spinoff Targeting A Huge Underserved MarketRead the original story

    3 hrs ago | Seeking Alpha

    ... disease. Marketed under names like Relvar / Breo Ellipta and Anoro Ellipta, they are a leader in treatment for COPD in partnership with GlaxoSmithKline (NYSE: GSK ). On June 2nd, Theravance completed a spin separating their business into two pieces ...


  2. Lung Cancer Risk Increases For Patients Previously Diagnosed With A Respiratory DiseaseRead the original story w/Photo

    Friday Aug 15 | Medical Daily

    ... of clinical surveillance needed for patients with each of these diseases." Chronic Obstructive Pulmonary Disease (COPD) is the official term for these respiratory diseases. According to the American Lung Association (ALA), COPD is the third leading ...


  3. Striverdi Respimat found to help COPD sufferers breathe easierRead the original story w/Photo

    Thursday Jul 31 |

    In an effort to help patients with Chronic Obstructive Pulmonary Disease (better known as COPD ) breathe easier, the FDA has approved the use of Striverdi Respimat (olodaterol) inhalation spray to relax the muscles around the airways in the lungs ...


  4. Findings from Tohoku University Yields New Data on Immunologic...Read the original story

    Wednesday Aug 13 | Hispanic Business

    , by NewsRx journalists, research stated, "Chronic obstructive pulmonary disease (COPD) is an intractable pulmonary disease, causes widespread and irreversible alveoli collapse. In search of a treatment target molecule, which is able to regenerate ...


  5. Umeclidinium/vilanterol outperforms monotherapies in COPDRead the original story w/Photo

    Wednesday Aug 13 | Medical News

    ... (VI) is more effective than each drug as monotherapy for the treatment of chronic obstructive pulmonary disease (COPD), research indicates. The results also suggest that the long-acting muscarinic antagonist/I22-agonist combination UMEC/VI 62.5/25 A ...


  6. 3 Value Stocks Worth BuyingRead the original story w/Photo

    Tuesday Aug 12 | The Motley Fool

    ... drop in constant currency). Specifically, expenses tied with launching its newer chronic obstructive pulmonary disease (COPD) drugs have been costly, and revenue of key COPD drug Advair, which has long since been off patent, continues to drop and ...


  7. WADA's drug war comes to TassieRead the original story w/Photo

    Tuesday Aug 12 | The Mercury

    ... for new technologies. "It is an absolutely fantastic drug for treating asthma, it really has revolutionised asthma and COPD treatment over the last 40 years. "Apart from antibiotics, of course, it is a significant drug for people with respiratory ...


  8. Aquinox Pharmaceuticals' (AQXP) CEO David Main on Q2 2014 Results - Earnings Call TranscriptRead the original story

    Monday Aug 11 | Seeking Alpha

    ... of AQX-1125 in the treatment in patients with exacerbation of Chronic Obstructive Pulmonary Disease, also known as COPD and Bladder Pain Syndrome Interstitial Cystitis or BPSIC for short. Now FLAGSHIP is a multinational double-blind ...


  9. Why people with COPD may be putting themselves at unnecessary riskRead the original story

    Sunday Aug 10 |

    ... is a frightening potential reality for an estimated 24 million Americans with chronic obstructive pulmonary disease (COPD), a progressive and debilitating lung disease that makes it difficult to breathe. Many COPD patients will experience an event ...


  10. Christchurch patients wanted for health studyRead the original story w/Photo

    Friday Aug 8 | The Press On-Line

    ... collectors. The trust leading the project, Sensing City, wants to recruit 150 chronic obstructive pulmonary disease (COPD) sufferers in collaboration with the Canterbury District Health Board (CDHB). They will be invited to sign up on a voluntary ...


  11. Miner due Black Lung benefits despite smoking history: CourtRead the original story

    Friday Aug 8 | Business Insurance

    ... of his lungs, according to court filings. Mr. Sterling, who had used an oxygen tank since 1995, was diagnosed with COPD after he was laid off. Mr. Sterling filed for benefits in October 2006 under the Black Lung Benefits Act. His claim was denied by ...


  12. Effectiveness of the Assessment of Burden of Chronic Obstructive...Read the original story

    Wednesday Aug 6 | BioMed Central

    ... , Denise Schuiten , Gerard van Breukelen , Daniel Kotz and Onno CP van Schayck Chronic Obstructive Pulmonary Disease (COPD) is a growing worldwide problem that imposes a great burden on the daily life of patients. Since there is no cure, the goal of ...


  13. Bayonne Medical Center, CarePoint Health charge $9K to bandage man's fingerRead the original story w/Photo

    Wednesday Aug 6 |

    ... -- part of a chain called CarePoint Healthcare -- charges the highest prices for several types of procedures, including COPD treatment, among the regional hospitals reviewed by HuffPost. Its price for that treatment runs four times the average in ...


  14. Actavis welcomes AZ in boosting its LAMA/LABARead the original story w/Photo

    Wednesday Aug 6 |

    ... was acquiring Barcelona, Spain-based drug delivery firm Almirall for $875m (a 650m) in order to enhance its asthma and COPD portfolio, whilst adding inhaler and particle technology technologies. Almirall was developing a fixed dose combination drug ...


  15. Aradigm to Host Analyst Meeting and Webcast on August 12 in New York CityRead the original story w/Photo

    Wednesday Aug 6 | Business Wire

    ... of the Lung Volume Reduction program at the New York-Presbyterian Hospital. He chairs the board of directors of the COPD Foundation. His areas of expertise are in Pulmonary Disease including non-CF BE, COPD, Emphysema, Asthma, and Interstitial Lung ...


  16. AstraZeneca coughs up $875m for Almirall to support asthma/COPD pipelineRead the original story w/Photo

    Monday Aug 4 |

    The total price of the Barcelona, Spain-headquartered pharma firm could reach $1.22bn following development, launch, and sales-related milestones, but its respiratory assets will strengthen the Pharma Giant's inhaled asthma and COPD portfolio, adding to the inhaler and particle technology acquired in the $1.5bn Pearl Therapeutics transaction in ... (more)


  17. AstraZeneca agrees to strategic transaction with Almirall in respiratory diseaseRead the original story w/Photo

    Saturday Aug 2 | Big News

    ... transaction, AstraZeneca will own Almirall's entire cadre of lung treatments and delivery devices, led by on-the-market COPD drug Eklira. It will have rights for the development and commercialisation of Almirall's existing proprietary respiratory ...


  18. FDA Approves Striverdi Respimat (Olodaterol) to Treat COPDRead the original story

    Friday Aug 1 | P&T Community

    ... Boehringer Ingelheim Pharmaceuticals) inhalation spray to treat patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema, who are experiencing airflow obstruction. COPD is a serious lung disease that ...


  19. Striverdi Respimat Approved to Treat COPDRead the original story

    Friday Aug 1 | Kansas City InfoZine

    Striverdi Respimat can be used once daily over a long period of time. COPD is a serious lung disease that makes breathing difficult and worsens over time.


  20. COPD Drug, Striverdi Respimat, Receives FDA ApprovalRead the original story w/Photo

    Friday Aug 1 | Medical Daily

    ... approved by the Food and Drug Administration (FDA) for once daily treatment of chronic obstructive pulmonary disease (COPD) afflicting millions of children and adults. The new long-term medication treats patients with COPD, including chronic ...